"10.1371_journal.pone.0150191","plos one","2016-03-02T00:00:00Z","Stig Palm Therkelsen; Geir Hetland; Torstein Lyberg; Idar Lygren; Egil Johnson","Department of Gastrointestinal and Pediatric Surgery, Oslo University Hospital, Ullev√•l, Norway; Immunology and Transfusion Medicine, Oslo University Hospital, Ullev√•l, Norway; Medical Biochemistry, Oslo University Hospital, Ullev√•l, Norway; Medicine, Oslo University Hospital, Ullev√•l, Norway; Faculty of Medicine, University of Oslo, Norway","Conceived and designed the experiments: SPT EJ. Performed the experiments: SPT EJ. Analyzed the data: SPT EJ. Contributed reagents/materials/analysis tools: SPT GH EJ. Wrote the paper: SPT GH EJ. Inclusion of patients and review of manuscript: IL. Laboratory setup and review of manuscript: TL.","Two of the authors (GH and EJ) have patent/patent applications and financial interests relating to material (AndoSan‚¢) pertinent to this article: i) WO2005065063 A2, Appl. No.:10/585600, NO- and PCT-filed Jan 2004 and Jan 2005, respectively, by Inventor Hetland Geir, and ii) NO20090003383, Appl. No.: NO20090003383 20091119, by Inventors Hetland Geir and Johnson Egil and filed by Applicant Immunopharma AS in Nov 2009 and financial interest of Geir Hetland as shareholder in Immunopharma AS of Norway, commercializing AndoSan‚¢. This does not alter the authors‚Äô adherence to PLOS ONE policies on sharing data and materials.","2016","03","Stig Palm Therkelsen","SPT",5,TRUE,2,2,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
